486 related articles for article (PubMed ID: 15937753)
1. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
[TBL] [Abstract][Full Text] [Related]
2. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
Turner SA; Maclean JD; Fleckenstein L; Greenaway C
Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
[TBL] [Abstract][Full Text] [Related]
3. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
Moura EB; Maia Mde O; Ghazi M; Amorim FF; Pinhati HM
Braz J Infect Dis; 2012; 16(5):479-81. PubMed ID: 22975175
[TBL] [Abstract][Full Text] [Related]
4. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
Leung V; Al-Rawahi GN; Grant J; Fleckenstein L; Bowie W
Am J Trop Med Hyg; 2008 Dec; 79(6):853-5. PubMed ID: 19052292
[TBL] [Abstract][Full Text] [Related]
5. Strongyloides hyperinfection in rheumatoid arthritis.
Das P; Raghu P; Amit Kumar Dinda ; Garg P
Int J Surg Pathol; 2007 Oct; 15(4):391-2. PubMed ID: 17913948
[No Abstract] [Full Text] [Related]
6. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
Manrique-Rodríguez S; Martín-Rabadán P; Díaz-Cámara M; Fernández-Llamazares CM
Med Clin (Barc); 2016 Apr; 146(8):376-7. PubMed ID: 26654554
[No Abstract] [Full Text] [Related]
7. Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.
Donadello K; Cristallini S; Taccone FS; Lorent S; Vincent JL; de Backer D; Jacobs F
Int J Antimicrob Agents; 2013 Dec; 42(6):580-3. PubMed ID: 24269075
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Arch EL; Schaefer JT; Dahiya A
Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
[TBL] [Abstract][Full Text] [Related]
9. Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report.
Grein JD; Mathisen GE; Donovan S; Fleckenstein L
Scand J Infect Dis; 2010 Mar; 42(3):234-6. PubMed ID: 20085425
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary strongyloidiasis.
Jayaprakash B; Sandhya S; Anithakumari K
J Assoc Physicians India; 2009 Jul; 57():535-6. PubMed ID: 20329418
[TBL] [Abstract][Full Text] [Related]
11. Use of Endoscopy to Strengthen a Diagnosis.
Grunwald D; Najarian R; Feuerstein JD
Gastroenterology; 2016 Apr; 150(4):825-6. PubMed ID: 26940888
[No Abstract] [Full Text] [Related]
12. Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient.
Briasoulis A; Psevdos G
South Med J; 2011 Jan; 104(1):72-3. PubMed ID: 21119560
[No Abstract] [Full Text] [Related]
13. Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literature.
Barrett J; Broderick C; Soulsby H; Wade P; Newsholme W
J Antimicrob Chemother; 2016 Jan; 71(1):220-5. PubMed ID: 26462990
[TBL] [Abstract][Full Text] [Related]
14. Dissemination: the fatal risk for a missed diagnosis of Strongyloides stercoralis infection.
Boscolo M; Bisoffi Z
J Infect; 2007 Sep; 55(3):284-5. PubMed ID: 17368549
[No Abstract] [Full Text] [Related]
15. Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infections in dogs.
Mansfield LS; Schad GA
J Am Vet Med Assoc; 1992 Sep; 201(5):726-30. PubMed ID: 1399774
[TBL] [Abstract][Full Text] [Related]
16. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
Benvenuti F; Carrascosa JM; Boada A; Ferrandiz C
Eur J Dermatol; 2009; 19(4):404-5. PubMed ID: 19467975
[No Abstract] [Full Text] [Related]
18. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
[TBL] [Abstract][Full Text] [Related]
19. Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock.
Salluh JI; Feres GA; Velasco E; Holanda GS; Toscano L; Soares M
Intensive Care Med; 2005 Sep; 31(9):1292. PubMed ID: 16041520
[No Abstract] [Full Text] [Related]
20. [An overview of Strongyloides stercoralis and its infections].
Ardiç N
Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
